Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Research Study Evaluating the Safety, Tolerability and Efficacy of Intranasally Administered Human FGF-1 in Subjects With Parkinson's Disease

NCT05493462 is registered in ClinicalTrials.gov with Zhittya Genesis Medicine, Inc. as lead sponsor.

NCT NCT05493462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05493462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Research Study Evaluating the Safety, Tolerability and Efficacy of Intranasally Administered Human FGF-1 in Subjects With Parkinson's Disease
Lead sponsor
Zhittya Genesis Medicine, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2022
Completion date
December 31, 2022
Enrollment
4 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease